Grifols SA reported its Q3 2025 revenues of EUR 1.865 billion and a net profit of EUR 127 million, with a year-to-date revenue of EUR 5.542 billion—an increase of 7.7% year-over-year. The filing was issued on November 4, 2025, detailing strong growth mainly from its Biopharma business.